A Periodical for the Sarcoma Community

September 2013 - Volume 10, Number 4

Enhanced Scope and New Publication Schedule

Editorial by Bruce Shriver, PhD

Developing Novel Therapeutic Options for Leiomyosarcoma

In this experimental plan, Matt van de Rijn MD, PhD and Santosh Gupta, PhD describe their studies on three potential therapeutic targets for leiomyosarcoma.

CD99 Engagement and Apoptosis in Ewing’s Sarcoma

Childhood Cancer Awareness Month

In this study report, Michela Rugolo, PhD and Katia Scotlandi, PhD discuss the molecular mechanisms underlying CD99-induced cell death, including the involvement of mitochondria and other crucial players in the process; and the role of mitochondrial DNA (mtDNA) mutations in Ewing's Sarcoma.

Childhood Cancer Awareness Month

September is Childhood Cancer Awareness Month. The Initiative honors and supports the families dealing with this difficult disease.


$150k Grant Funds Research on Targeted Therapies for Leiomyosarcoma

The LeioMyoSarcoma Direct Research Foundation and the Liddy Shriver Sarcoma Initiative are funding a promising study on LMS at Stanford University.

Translated Articles

Condrosarcoma Mesenchimale

Marilena Cesari, MD provides an Italian translation of the ESUN review article on mesenchymal chondrosarcoma.


Keisuke Akaike, MD and Yoshiyuki Suehara, MD, PhD provide a Japanese translation of the ESUN review article on desmoplastic small round cell tumor.